Growth Metrics

Quest Diagnostics (DGX) Operating Income (2016 - 2025)

Historic Operating Income for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $386.0 million.

  • Quest Diagnostics' Operating Income rose 1696.97% to $386.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2228.43%. This contributed to the annual value of $1.3 billion for FY2024, which is 665.61% up from last year.
  • Latest data reveals that Quest Diagnostics reported Operating Income of $386.0 million as of Q3 2025, which was up 1696.97% from $438.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Operating Income registered a high of $660.0 million during Q1 2021, and its lowest value of $135.0 million during Q4 2022.
  • Over the past 5 years, Quest Diagnostics' median Operating Income value was $361.0 million (recorded in 2024), while the average stood at $399.3 million.
  • Its Operating Income has fluctuated over the past 5 years, first skyrocketed by 27714.29% in 2021, then crashed by 7481.34% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Operating Income stood at $536.0 million in 2021, then tumbled by 74.81% to $135.0 million in 2022, then surged by 97.78% to $267.0 million in 2023, then skyrocketed by 35.21% to $361.0 million in 2024, then grew by 6.93% to $386.0 million in 2025.
  • Its Operating Income stands at $386.0 million for Q3 2025, versus $438.0 million for Q2 2025 and $346.0 million for Q1 2025.